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The association of 17fl-estradiol with an 8 S bind- 
ing protein in the cytoplasm is a generally acknowl- 
edged primary step in the cellular action of the steroid 
hormone. The complex crosses the nuclear membrane 
either before or after conformational change of the 
protein to a 5 S species [ I] . The presence of an 
estrogen receptor in the pituitary is well documented 
[2-51 and the ontogeny of the pituitary cytosol 
17P-estradiol receptor was described recently [6]. In 
addition, the actions of estrogen on the hypo- 
thalamus-pituitary axis have been studied extensively. 
Little is known, however, about the molecular mecha- 
nisms of LH-RH stimulated gonadotropin release 
modulated by 17flestradiol at the pituitary level. 
The‘present experiments were designed to study 
the translocation of the pituitary estrogen-receptor 
complex into the nucleus in rats under in vivo and in 
vitro conditions. Furthermore, the effect of castration 
on the translocation process in the hypothalamus and 
pituitary of female rats was investigated. We were 
prompted to report these data since they add further 
evidence that estrogen stimulated translocation of 
the pituitary 17flestradiol receptor from the cytosol 
to the nucleus is a primary event in the mechanism of 
action of this steroid. 
2. Materials and methods 
Rats of the Sprague Dawley strain (Him: OFA 
(SD) SPF, Forschungsinstitut fur Versuchstierzucht , 
University of Vienna, Austria) were used throughout 
this study. The animals were housed in a temperature- 
controlled room lighted for 12 h/day and unrestricted 
access was provided to food and water. Intact adult 
female animals weighing 175-200 g and rats 30 days 
after castration, respectively, were used in the in vivo 
translocation experiments. 17/3-Estradiol, 1.5 pg in 
0.5 ml 2.5% aqueous alcohol, was injected i.p. 20, 
40,60 and 120 min before killing the rats. Control 
animals were treated with estrogen-free aqueous 
alcohol. In the experiments with castrated animals 
the rats were sacrificed 60 min after the injection. 
The animals were killed by decapitation, hypothalami 
and pituitaries were excised and placed in chilled 
TMK-buffer (0.01 M Tris, 0.0015 M MgC12,0.01 M 
KCI, pH 7.2). The posterior lobes of the pituitaries 
were removed and discarded. All further procedures 
were done at 0-4°C. Six glands/ml TMK-buffer were 
homogenized by 10 strokes at 500 rev/min in a glass- 
Teflon Potter Elvehjem type homogenizer. The homo- 
genate was centrifuged at 800 X g for 10 min. The 
pellet which contained the nuclear fraction was 
washed 3 times by resuspension in 5 ml TMK-buffer 
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and recentrifugation. Nuclei obtained from 36 anterior 
pituitaries were resuspended in 10.8 ml TMK-buffer. 
The purity of the preparation was checked by phase- 
contrast, fluorescence and electron microscopy, 
which revealed intact nuclei with only little contami- 
nation. The supernatant of the 800 X g centrifugation 
of the total homogenate was spun in a Beckmann 
Spinco LS 2-65 B preparative ultracentrifuge at 
110 000 X g (av.) for 60 min in order to obtain the 
cytosol fraction. 
Binding assays of the cytosol preparations at 
various times after estrogen administration were 
performed as described previously [6] . Briefly, 
0.4 ml cytosol samples were incubated with 17fl-[3H] 
estradiol at concentrations ranging from 2.0 X lo-’ 
to 3.5 X lo-” M in the presence and absence of a 
lOOO-fold excess of unlabeled estrogen. After incuba- 
tion overnight 0.2 ml of a charcoal suspension (0.6% 
charcoal Norit-A, 0.06% Dextran T-70,0.1 % gelatine, 
0.1 M phosphate buffer, pH 7.4) was added. The 
incubation mixture was centrifuged and the radio- 
activity of the supernatant was determined. 
Quantitative estimation of the nuclear receptor- 
hormone complex was performed according to 
methods described previously [8] by incubating 1 .O 
ml nuclei suspensions obtained at various times after 
the estrogen injection with 17/3-[sHIestradio at con- 
centrations ranging from 0.5 X lo-’ M to 1 X 10-s M, 
in the presence and absence of a lOOO-fold excess of 
unlabeled 17/3-estradiol to account for unspecific 
binding. The incubation was performed in triplicates 
at 37°C for 30 min. The reaction was stopped by 
transferring’the incubation tubes to an ice-bath and 
adding 3 ml chilled TMK-buffer. After centrifugation 
at 800 X g the pellet was washed 2 times with 3 ml 
TMK-buffer by resuspension and recentrifugation. The 
pellet was extracted with 3 ml absolute ethanol by 
vortexing and was left at room temperature for 10 
min. Thereafter the tubes were centrifuged at 3000 X g 
for 10 min, and the radioactivity of the supernatant 
determined. 
The number of 17@-estradiol-binding sites and 
apparent affinity constants were estimated by 
Scatchard plot analysis [7]. 
Experiments on the in vivo translocation were 
also done with IS-day old female rats. Groups of 
30 animals each were injected S.C. with 25 pg 17/3- 
estradiol in 0.5 ml physiological saline solution contain- 
ing 10% ethanol kept at 37°C. Control animals were 
killed after an injection with an estrogen-free solution. 
The estrogen-treated animals were sacrificed 30 min 
and 60 min, respectively, after the injection. Prepara- 
tion of cytosol samples, incubation with 17fl-[3H] 
estradiol and sucrose-gradient centrifugation was 
carried out as described previously [6] . 
In experiments on the in vitro translocation 30 
female rats weighing 175-200 g were used 3 days 
after ovariectomy. Cytosol and nuclei fractions were 
obtained as described for the in vivo experiments. 
The cytosol(4.5 ml) was incubated with 17&[3H] 
estradiol (1 X 10e9 M) for 2 h. Saturation of binding 
sites was recorded after 90 min incubation at 4°C (our 
unpublished data). Thereafter, the cytosol was treated 
with 2.25 ml charcoal suspension for 20 min and the 
3H-labeled cytosol was used for further experiments 
after centrifugation at 3000 X g for 10 min. The 
nuclear pellet was resuspended in TMK-buffer and 
aliquots were tilled into incubation tubes. Subsequent 
to centrifugation (800 X g) these nuclear pellets 
were resuspended in aliquots of 3H-labeled cytosol 
samples. After mixing incubation was done in a water 
bath shaker at 25°C for 3,5,10, 15 and 30 min. The 
reaction was stopped by adding 8 vol. TMK-buffer 
at 0-4°C. The mixture was centrifuged at 3000 X g 
for 10 min and the radioactivity of the supernatant 
was determined. The pellet was extracted with 3 ml 
absolute ethanol to estimate nuclear bound radio- 
activity. 
3. Results and discussion 
The translocation of the pituitary cytosol 17/3- 
estradiol-receptor complex to the nucleus was 
monitored by estimating the number of estrogen- 
binding sites in the cytosol and by determining the 
nuclear binding capacity after the administration of 
a single dose of 17flestradiol (Bg.1). Apparent 
affinity constants of 2.3 X 10” M-’ and 1.0 X lo9 
M-’ , respectively, of cytosol and nuclear binding 
sites were estimated. A rapid depletion of cytosol 
17/I-estradiol receptor sites was recorded. About 90% 
of the pituitary cytosol binding sites are lost after 
administration of estrogen. The depletion period 
reaches a low about 20 min after estrogen. Thereafter 
a slow replenishment of binding sites occurs and 
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Fig. 1. Translocation of the pituitary 17fl-estradiol receptor 
complex from the cytosol to the nucleus after a single s.c. 
injection of 1.5 #g estrogen in adult female rats. 
26% of the control evels are attained 120 rain after 
estrogen treatment. Concomitantly, a 3.5-fold increase 
over control evels of nuclear binding was noted and 
maximal nuclear eceptor concentration was registered 
20 min after the application of 17/~-estradiol. At 60 
rain 63% of maximal nuclear binding was noted. 
Thereafter a slow loss of  17/3-estradiol from the 
nucleus was found and 120 min after estrogen admini- 
stration, nuclear binding was still elevated 2-fold over 
control evels. It is interesting to note that the loss of 
bound estrogen from the nucleus between 20 min and 
40 min after estrogen is faster than the replenishment 
of cyto+plasmatic binding capacity during the same 
period. Data shown in fig.1 suggest that long-term 
retention of the nuclear estrogen-receptor complex 
may be necessary for delayed actions of the steroid 
hormone. In addition, the concomitant loss of bound 
17/~-estradiol from the nucleus and the replenishment 
of cytosol binding protein may indicate a direct 
relationship between these two events. These results 
provide further evidence that an in vivo injection of 
17/~-estradiol translocates a cytoplasmic receptor 
complex into the nucleus. The time-course of the 
accumulation of  nuclear estrogen-receptor complex 
described in the present communication is different 
from pafterns reported for immature rats recently 
[8]. Specific nuclear uptake was maximal 1 h after 
estrogen application and about 6-times higher than 
control evels. This discrepancy may be due to the 
fact that the translocation process is dependent upon 
the developmental stage of the animal, since changes 
in the pituitary nuclear uptake of 11/3-[6,7-3H] 
methoxy-17-ethinylestradiol in rats at different ages 
were described recently [9]. 
Data shown in table 1 suggest that the estrogen 
stimulated loss of cytoplasmic receptor content 
depends on endogenous steroid hormone levels. A 
depletion of 17/3-estradiol-binding sites in the pituitary 
cytosol to 7.5% and 1.6% of control evels, respec- 
tively, is recorded in intact and castrated adult female 
rats 60 min after a single s.c. injection of  estrogen. 
Similar effects can be noted in experiments with the 
hypothalamus (data not shown). The cytosol receptor 
is depleted to 23.1% and 8.6% of control evels, 
respectively, in intact and ovariectomized rats. On 
the other hand no significant changes of the apparent 
affinity constants are registered (table 1). 
In an attempt o evaluate the biological role of 
the pituitary 4 -5  S 17/3-estradiol-binding protein 
found in the cytosol at early stages of development 
of the rat [6] we investigated the estrogen stimulated 
loss of this binding component in 15-day old female 
rats (fig.2). Thirty minutes after a single s.c. injection 
of 25/ag 17/3-estradioi nly some 60% of control 
levels of the 4 -5  S moiety could be found. At 60 
Table 1 
Apparent affinity constants (K) and number (n) of cytosol 17#-estradiol receptor sites of 
anterior pituitary in adult female rats before and 30 days after castration 
K (X 10 I° M -j ) n (X 1014 mol/mg protein) 
Intact Castrated Intact Castrated 
Control 2.3 3.2 18.6 31.0 
Estrogen- 
treated 3.8 1.1 1.4 0.5 
Data were obtained in control animals and rats 60 min after s.c. of 1.5 ug 17O-estradiol 
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min an almost complete depletion was noted. The 
effect seems to be dose dependent, since the injection 
of 5 yg 17fl-estradiol provokes only a 20% loss and a 
single S.C. administration of 0.5 pg estrogen does not 
affect the 4-5 S binding component (our unpublished 
data). On the other hand, a complete loss of the 8 S 
moiety was observed 30 min after a single injection of 
0.5 pg, 5 pg and 25 bg, respectively, of l’l&estradiol. 
These data suggest a translocation of the 8 S and 4-5 
S cytosol receptors. But, the present data do not allow 
to rule out that the 4-5 S moiety may be identical 
with fetal rat estradiol binding plasma protein [ 141 
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Fig.2. Sucrose-gradient a alysis of pituitary 17p-estradiol-binding protein of 15day old rats at various times after a single S.C. 
injection of 25 pg 17pestradiol. 
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Fig.3. In vitro translocation of the pituitary 17pestradiol 
receptor complex obtained from adult female rats 3 days 
after castration. 
due to a possible contamination of freshly prepared 
pituitaries with plasma proteins. 
Similarly, data recorded for in vitro experiments 
performed with cytosol and nuclear fractions obtained 
from adult female rats (fig.3) indicate nuclear translo- 
cation of the cytosol8 S binding protein, which was 
previously shown to be the sole cytoplasmic estrogen 
receptor in adult rats [6] . Discrepancies observed in 
the patterns of in vivo (fig.1) and in vitro (fig.3) 
translocation experiments may be due to differences 
in the transformation step of the cytosol receptor 
[I] prior to the translocation. 
Data of the present experiments combine to 
suggest hat the translocation of the 8 S moiety of 
the 17j%estradiol-receptor complex of rat anterior 
pituitary from the cytosol to the nucleus may be 
,one of the primary steps involved in the modulation 
by estrogen of LH-RH stimulated gonadotropin 
release [ 121 and in the estrogen provoked prolactin 
release, respectively, [ 131 But, further work is 
necessary to elucidate this mechanism and to prove 
the biological role of the 4-5 S 17@stradiol-binding 
protein found in the cytosol of immature rats. 
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